10 Years After HIV PrEP Approval, Uptake Lowest Among Highest Risk Groups
Expanding Medicaid and reducing stigma can bolster equitable HIV PrEP access, Dr. Patrick Sullivan says.
Biktarvy Effective for HIV Patients Coinfected With Hepatitis B
At AIDS 2022, Gilead presented data suggesting Biktarvy was a safe and effective complete HIV treatment regimen, including for those coinfected with hepatitis B.
Fostemsavir Improves Outcomes for Treatment-Resistant HIV Patients
After 5 years of treatment, fostemsavir improved immunologic response and virologic outcome in patients with highly resistant HIV infection.
Getting Younger People on PrEP
Why it's critical for the future of HIV prevention for programs like the California PrEP-AP to reach younger at-risk persons now.
The Social Hurdles of HIV Awareness and Prevention
How a sexually-transmitted virus is hindered by limited marketing, and how its stigmas compare to those developing around COVID-19.
Addressing HIV Stigma in MSM
Why men who have sex with men face social hurdles in seeking PrEP and preventive education.
Evolving PrEP to Patient-Friendly Standards
How regional-based data and advancing preventive options could bolster individual HIV-risk care access.
Remdesivir: Gilead Touts Promising Coronavirus Outcomes Across Race & Ethnicity
Findings were announced during the special COVID-19 sessions of the virtual 23rd International AIDS Conference.
Why Fewer At-Risk Men Take HIV PrEP
A study looking at PrEP population obstacles shows men who have sex with men are more likely to not seek out information nor access to prophylaxis.
HIV Screening: Are Primary Care Physicians Following CDC Guidelines?
Dr. Marc Pitasi, epidemiologist, discusses facilitators of routine HIV screening among primary care physicians.
Telehealth Seen as Viable Option for Same-Day ART Patients
A small study shows a majority of HIV patients open to both starting ART and follow-up telehealth appointments.
How California is Improving PrEP Access
A discussion around new data presented at AIDS 2020 which shows statewide strategies are breaking down barriers.
Cash for Clinic Visits: Financial Incentive Boosts HIV Viral Suppression
Investigators in Tanzania trialed modest, automated financial incentives for clinic attendance on viral suppression for patients initiating ART.
A Candid Look at PrEP Usage
In a large study, an examination of patterns of use.
In Developing World, Pharmacies Can Play Important Role for HIV Patients
In developing countries with overcrowded hospitals, community pharmacies can relive burden, help HIV patients.
Long-Term PrEP Continuum of Care Patterns
Uncovering interesting findings regarding patients' PrEP regimen.
COVID-19 vs HIV: How the Epidemics Compare
How much does the current virus crisis share in common with early HIV outbreak scare?
Time of US HIV Infection to Diagnosis Decreases
Time interval goes down by 3 months in 3 year period.
Event-Driven PrEP Patients Face Retention Issues in Thai Study
Investigators compared characteristics and retention between daily and event-driven PrEP patients to better understand low uptake of event-driven PrEP.
Overdose Deaths Encroach on Life Expectancy Gains Among People Living With HIV
Experts assessed the impact of drug overdoses on people living with HIV in British Columbia, identifying factors associated with mortality using competing risk methodology.
Money, Pills, and Isolation: Survey Reveals Concerns of Aging Patients With HIV
People with HIV are living longer than ever at present time, raising quality of life concerns about later stage medical and psychological challenges comorbidities.
COVID-19 Mortality Rates and Outcomes for HIV Patients Better Than HIV-Negative Group
Small study shows HIV patients not at a greater risk for worse outcomes.
California PrEP Push Reveals Underserved Demographics
The California PrEP Assistance Program, established to remove financial and structural barriers to PrEP access, had positive but uneven initial results.
The Burden of Multidrug-Resistant HIV
With fostemsavir now available for patients with few options, an expert discusses what challenges MDR-HIV patients face in their care.
Urine HIV Self-Testing in China Shows Effectiveness
With insufficient HIV diagnosis testing in that country, this novel testing could help it reach part of its UNAIDS 90-90-90 targets.
First Possible HIV Remission Case without Bone Marrow Transplant Observed
A 34-year-old Brazilian man's HIV was undetectable 57 weeks after ending a heightened regimen of ART.
Fostemsavir Benefits Multi-Drug Resistant HIV
A look at the BRIGHTE study data which evidenced the recently FDA-approved add-on agent.
Switching to Second-Line Therapy Versus First-Line Antiretroviral
In low-level HIV-1 viraemia patients, this strategy demonstrated viral suppression in more than half of a study's participants.
Survey: Two-Thirds of US Adults Have Not Received HIV Testing
Despite being recommended at least once among all persons aged 13-64 years old by the CDC, notably few respondents have ever been tested for HIV.
Combatting Virologic Failure in Children with HIV using Targeted Drug Resistance Testing
Guidelines recommend concentrated adherence counseling and frequent viral load testing for virologic failure, but drug resistance testing is often excluded.
2 Clarke Drive Cranbury, NJ 08512